Who's buying Dogwood Therapeutics, Inc.?

DWTX insider buying, 13F and 13D filings

• Oct 21, 202613D stake (no activist plan)
  Sealbond Limited (+2): Amended Schedule 13D: 72.3% stake
  Item 4 is hereby amended to add the following: Subscription Agreement On October 19, 2026, Dogwood Therapeutics, Inc. (the "Company") entered into a Subscription Agreement (the "Subscription Agreement") with Sealbond Limited ("Sealbond"), pursuant to which the Company agreed to i…
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.